Avanos Medical Merger with AIP Clears Regulatory Hurdles, Nearing $1.27B Close
AVNS has more than doubled off its 52-week low of $9.303.
Summary
Avanos Medical and American Industrial Partners have secured all necessary regulatory approvals for their pending $1.27 billion merger. This critical development removes a major condition for the acquisition, significantly increasing the certainty of the deal closing. The merger, announced on April 14th at $25.00 per share, is now primarily contingent on Avanos stockholder approval at a special meeting scheduled for July 22nd. The transaction is expected to finalize no later than July 27th, bringing the company closer to its acquisition by AIP.
At the time of this announcement, AVNS was trading at $24.89 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $9.30 to $25.49. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.